Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 250 of 399 entries
View as:

Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01533948 Org: User:
Start: 01/31/12 End: 07/31/15 Due: 07/31/16

Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04119830 Org: User:
Start: 02/01/22 End: 02/01/24 Due: 02/01/25

Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy

Phase: N/A Priority: Normal
NCT ID: NCT04646434 Org: User:
Start: 07/13/23 End: 07/13/29 Due: 07/13/30

Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06202066 Org: User:
Start: 06/15/25 End: 10/15/28 Due: 10/15/29

An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT06414317 Org: User:
Start: 01/12/24 End: 01/01/26 Due: 01/01/27

Financial Health Educational Program for Increasing Financial Literacy Among Underserved Communities in Western New York

Phase: N/A Priority: Normal
NCT ID: NCT05997589 Org: User:
Start: 05/17/23 End: 02/24/25 Due: 02/24/26

Altretamine and Etoposide in Treating Patients With HIV-Related Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002936 Org: User:
Start: 07/31/96 End: - Due: -

Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia

Phase: N/A Priority: Normal
NCT ID: NCT01236417 Org: User:
Start: 03/31/10 End: - Due: -

Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With Stage I or Stage II Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00003974 Org: User:
Start: 08/31/97 End: 11/30/00 Due: 11/30/01

Photodynamic Therapy in Treating Patients With Skin Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002975 Org: User:
Start: 02/28/97 End: 04/30/10 Due: 04/30/11

Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03751449 Org: User:
Start: 03/25/19 End: 05/21/21 Due: 05/21/22

Irinotecan and Gemcitabine in Treating Patients With Recurrent or Progressive Stage III or Stage IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00182806 Org: User:
Start: 09/30/04 End: 07/31/08 Due: 07/31/09

Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02029417 Org: User:
Start: 07/31/14 End: 12/31/15 Due: 12/31/16

Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03727061 Org: User:
Start: 07/10/19 End: 10/22/24 Due: 10/22/25

TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study

Phase: N/A Priority: Normal
NCT ID: NCT04109924 Org: User:
Start: 12/27/19 End: 07/18/25 Due: 07/18/26

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01174199 Org: User:
Start: 02/29/12 End: 08/31/16 Due: 08/31/17

Thermal Therapy for the Treatment of Depression in Cancer Survivors, the S-WARM Study

Phase: N/A Priority: Normal
NCT ID: NCT04803630 Org: User:
Start: 05/06/21 End: 05/06/27 Due: 05/06/28

PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis

Phase: N/A Priority: Normal
NCT ID: NCT06055231 Org: User:
Start: 07/01/25 End: 06/15/26 Due: 06/15/27

Autofluorescence Detection of Oral Malignancies and Database and Biospecimen Collection to Identify Biomarkers of Head and Neck Tumor Progression

Phase: N/A Priority: Normal
NCT ID: NCT01531881 Org: User:
Start: 03/31/06 End: 01/31/14 Due: 01/31/15

Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers

Phase: N/A Priority: Normal
NCT ID: NCT01800500 Org: User:
Start: 09/30/11 End: - Due: -

Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01744171 Org: User:
Start: 03/26/13 End: 06/11/18 Due: 06/11/19

Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01527149 Org: User:
Start: 12/06/11 End: 01/11/24 Due: 01/11/25

Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease

Phase: N/A Priority: Normal
NCT ID: NCT04836429 Org: User:
Start: 03/10/22 End: 01/03/26 Due: 01/03/27

Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT04502095 Org: User:
Start: 09/02/20 End: 03/15/25 Due: 03/15/26

Alpha-Stim AID® Together With Life Coaching for the Support of Burnout Symptoms in Healthcare Workers

Phase: N/A Priority: Normal
NCT ID: NCT06977503 Org: User:
Start: 06/15/25 End: 05/15/27 Due: 05/15/28